Scribe Therapeutics Inc. (SCTX)
NASDAQ: SCTX · Real-Time Price · USD
16.69
+0.99 (6.31%)
At close: Nov 9, 2026, 4:00 PM EST
16.53
-0.16 (-0.96%)
After-hours: Nov 9, 2026, 5:20 PM EST
Scribe Therapeutics Employees
Scribe Therapeutics had 82 employees as of June 30, 2026. That makes Scribe Therapeutics the 32,606th largest employer in the world and 4,229th in the United States.
Employees
82
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$406,122
Profits / Employee
-$393,951
Market Cap
315.97M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 82 | - | - |
| Mar 31, 2026 | 89 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| ARS Pharmaceuticals | 206 |
| Cabaletta Bio | 158 |
| Kyverna Therapeutics | 149 |
| Nautilus Biotechnology | 128 |
| Ocugen | 116 |
| Arcturus Therapeutics Holdings | 111 |
| Century Therapeutics | 78 |
| Vicore Pharma Holding AB | 40 |
SCTX News
- 4 days ago - Scribe Therapeutics to Participate in Upcoming Healthcare Investor Conferences - GlobeNewsWire
- 5 days ago - Scribe Therapeutics to Present Updated Data on PCSK9-Targeting Epigenetic Silencing and LPA-Targeting Gene Editing Programs at American Heart Association (AHA) Scientific Sessions 2026 - GlobeNewsWire
- 6 weeks ago - Cathie Wood’s ARK Investment buys 143.3K shares of Scribe Therapeutics today - TheFly
- 2 months ago - Scribe Therapeutics reports Q2 EPS ($2.62), consensus ($3.72) - TheFly
- 2 months ago - Scribe Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 2 months ago - Scribe Therapeutics Earnings release: Q2 2026 - Filings
- 2 months ago - Scribe Therapeutics Quarterly report: Q2 2026 - Filings
- 2 months ago - Scribe Therapeutics Slides: Investor presentation - Filings